Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Semaglutide: A Proven GLP-1 Option Semaglutide, the active ingredient in Wegovy and Ozempic, is a GLP-1 receptor agonist specifically approved by the FDA for chronic weight management
Consulting with local dermatologists or cosmetic surgeons before making decisions about treatment abroad can help ensure safe and effective results
The cell line is ideal for screening candidate molecules for GLP-1 agonist activity and determining EC 50 dosing
Influence of liver disease on a healthy gut Liver disease can affect the microstructure and function of the gastrointestinal tract through several interconnected mechanisms
Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease
US$ 21.76
US$ 26.59
US$ 23.05
US$ 22.29
